inVerse - Multiple Sclerosis as a case study

Multiple sclerosis (MS) is a progressive, immune-mediated disorder.

That means the system designed to keep your body healthy mistakenly attacks parts of the body that are vital to everyday functioning. The protective coverings of nerve cells are damaged, which leads to diminished function in the brain and spinal cord.

MS is a disease with unpredictable symptoms that can vary in intensity: while some people experience fatigue and numbness, severe cases of MS can cause paralysis, vision loss, and diminished brain function.

MS is a challenging disorder, but researchers have discovered many treatments that can slow its progression.

MS is a progressive disease

MS Disease progression tp
MS Optum Annual Claim costs US
MS Optum Disease Progression

The cost of MS trials

Research costs

inVerse - MS Case study Results

The question to be answered for personalised treatment discovery was formulated as follows: Is it possible to analyze clinical trials conducted for multiple sclerosis (MS) and find potential signals which could help to identify candidate personalised therapies?

inVerse - MS Case Study - the case for change

Using inVerse learning from aggregates capabilities we show here that by enabling granular insights and learnings from aggregate data such as successful and failed clinical trials, we can derive massive value for Payers and Healthcare systems.